Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Comment by Skipabeat22on Nov 15, 2021 2:39pm
186 Views
Post# 34128458

RE:ON THE LIST!

RE:ON THE LIST!

Interesting to say the least...

"To establish the performance characteristics of the AcuVid COVID-19 Rapid Antigen Saliva Test in a point-of-care (POC)
CLIA Waived setting with lay users (no laboratory experience) testing a participant that has self-collected a saliva specimen."

So what does CLIA Waived mean: Every laboratory system, examination and assay is categorized for its level of complexity and
assigned subsequent scores thereafter. It is the CLIA’s responsibility to ensure standards for clinical laboratory testing are
maintained and that the test results remain accurate, reliable and relevant no matter where the test was conducted. To have a
waived certification implies that the specific test is not only relatively simple to conduct, but has a low potential for
displaying an erroneous result.

This means that such tests are safe to be performed at home or in non-laboratory settings thereby
making it easier and economical for patients to monitor their medical conditions. Moreover, besides the privacy of one’s home,
such tests can be performed in other non-laboratory settings like community health centres, counselling centres, pharmacies,
ambulances, nursing homes, and physicians’ offices.

<< Previous
Bullboard Posts
Next >>